Developing a quick blood test for diagnosing stroke
mRNA Expression Profiling from Extracellular Vesicles (EVs): Generating a Rapid Diagnostic for Stroke
This study is working on a quick test that can help doctors diagnose a stroke in about 31 minutes by looking at tiny particles in your blood, which could lead to faster treatment and better outcomes for stroke patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project ID | NIH-11083697 on NIH RePORTER |
What this research studies
This research focuses on creating a rapid diagnostic test for acute ischemic stroke (AIS) using mRNA expression profiling from extracellular vesicles in peripheral blood. The goal is to develop a point-of-care test that can provide results in approximately 31 minutes, allowing for timely treatment of stroke patients. By analyzing specific white blood cell markers that change rapidly after a stroke, the research aims to improve the accuracy and speed of stroke diagnosis compared to current imaging methods. This innovative approach could significantly enhance patient outcomes by facilitating quicker medical intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are experiencing symptoms of a stroke or have recently suffered a stroke.
Not a fit: Patients who have chronic neurological conditions unrelated to stroke may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of stroke, potentially saving lives and improving recovery outcomes.
How similar studies have performed: Previous research has shown promise in using blood-based biomarkers for stroke diagnosis, indicating that this approach could be effective.
Where this research is happening
Lawrence, United States
- University of Kansas Lawrence — Lawrence, United States (Active)
Researchers
- Principal investigator: Soper, Steven Allan — University of Kansas Lawrence
- Study coordinator: Soper, Steven Allan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.